pcos and tirzepatide Semaglutide & with PCOS: Envizion Medical: Wellness Center Beyond weight loss: tirzepatide helps
Description
This gradual increase minimizes nausea (reported in 20-30% of patients) while building tolerance
LBA 41 Gao, L
A recent head-to-head trial of the peptide drugs found that Lillys tirzepatide, which targets both GLP-1 and GIP receptors, produced greater average weight reductions than Novos semaglutide which targets only GLP-1
Loved by 1,500,000+ Canadians across Canada
The 24.2% weight loss at 48 weeks and 28.7% at 68 weeks came from weekly injections
Other Tests That May Be Used In some cases, doctors may use extra tools to monitor blood pressure
